Trial Profile
Effects of Denosumab on Bone Mineral Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot Study
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 31 Oct 2022
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Bone disorders
- Focus Therapeutic Use
- 31 Oct 2022 Primary endpoint has been met. (postero-anterior (PA) lumbar spine aBMD by dual-energy x-ray absorptiometry), as per Results published in the European Journal of Endocrinology
- 31 Oct 2022 Results published in the European Journal of Endocrinology
- 23 Jul 2021 Status changed from active, no longer recruiting to completed.